Stratified Medicine: Eminence elect
21.06.2013 - The Stratified Medicine Scotland Innovation Centre will kick off in 2015 with a global life science entrepreneur at its helm. Dr David U’Prichard was selected as the first Chairman of the £20m Innovation Centre.
U’Prichard is currently president of US-based pharmaceutical and biotechnology consulting firm Druid Consulting LLC. He is also the chief scientific officer at BioMotiv LLC and a member of the corporate boards of Life Technologies Inc (now ThermoFisher Scientific), Cyclacel Inc, and Iroko Pharmaceuticals LLC. Originally from Rothesay (Scotland), but now based in Philadelphia, the new chairman has pharma-cology degrees from the University of Glasgow and the University of Kansas. He has held academic appointments at Northwestern University, Johns Hopkins University and the University of Penn-sylvania, and is an Honorary Professor at the University of Glasgow. U’Prichard has authored more than 100 publications and is a member of various editorial boards.